drugset / Trial / NCT04124926
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy and safety of vonoprazan compared to lansoprazole in participants with erosive esophagitis.
Timeline
- Start
- 2019-10-28
- Primary completion
- 2021-07-29
- Completion
- 2021-08-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lansoprazole | Other / unclassified | 15 mg | Oral |
| Comparator | Lansoprazole | Other / unclassified | 30 mg | Oral |
| Subject | Vonoprazan | Other / unclassified | 10 mg | Oral |
| Subject | Vonoprazan | Other / unclassified | 20 mg | Oral |